CA2265906C - System for delivery of drugs by transport - Google Patents

System for delivery of drugs by transport Download PDF

Info

Publication number
CA2265906C
CA2265906C CA002265906A CA2265906A CA2265906C CA 2265906 C CA2265906 C CA 2265906C CA 002265906 A CA002265906 A CA 002265906A CA 2265906 A CA2265906 A CA 2265906A CA 2265906 C CA2265906 C CA 2265906C
Authority
CA
Canada
Prior art keywords
substance
permeable medium
platen
outer boundary
pressure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002265906A
Other languages
French (fr)
Other versions
CA2265906A1 (en
Inventor
Dean L. Kamen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Deka Products LP
Original Assignee
Deka Products LP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deka Products LP filed Critical Deka Products LP
Publication of CA2265906A1 publication Critical patent/CA2265906A1/en
Application granted granted Critical
Publication of CA2265906C publication Critical patent/CA2265906C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0038—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles having a channel at the side surface
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0046—Solid microneedles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
    • A61M2037/0053—Methods for producing microneedles

Abstract

A method and apparatus for introducing a fluid agent into body tissue by causing transport of the fluid agent into the dermis of the subject. The out er surface of the skin of the subject is drawn against a plurality of micropenetrators such that microfissures are cloven into the epidermis and fluid may be introduced for diffusion or suction within the dermis. Suction creates a pressure gradient within the dermis to cause fluid take-up by the dermal tissue. The micropenetrators are produced by punching an array of protrusions in the surface of a thin sheet creating sharp edges for penetrating the epidermis.

Description

CA 02265906 l999-03- llwo 93/11937 PCT/US97/16454System for Delivery of I)rugs by TransportTechnical Field5 The present invention pertains to a system for delivering therapeutic substancesinto the body, and, in particular, to a convenient method and device for providingtransport of fluid with minimal invasion of the dermis.Background of the Invention10 Delivery of therapeutic fluid agents through the skin requires penetration of thestratus corneum, the outer layer of the epidermis, and the layer of skin which normallyprovides a largely impervious barrier to the flow of microbes and most other materialsinto or out of the body. Penetration of the epidermal layer is conventionally accomplishedby means of a hollow needle or cannula, beveled at the penetrating end so as to provide a15 sharp point for local shearing of the skin, both at the surface, and in the course ofcontinued penetration, as the needle is driven down through the epidermal layers into thedermis. Some known methods apply suction around the injecting cannula to distend orengorge the underlying blood vessels, in order more efficiently to achieve intravenousinfusion of material. Since the dermis contains live nerve cells, the penetration of the20 needle is often uncomfortable to a patient.Among the methods known for introducing drugs or other therapeutic agents intothe body, some employ a multiplicity of needles. The known methods employing multipleneedles require devices which are difficult to fabricate and therefore costly.Other methods are known in the art for introducing therapeutic agents into the25 dermis so that they can be taken up by the circulatory system and distributed within thebody to clinical advantage. One such method is simple topical application, such as apatch, which relies upon slow diffusion of the agent through the epidermis. Anothermethod employs ajet injector whereby one or more streams of fluid agent are drivenforcibly through the epidermis without further mechanical separation of the outer tissue3() layer. These methods, reliant upon passage of fluid through the epidermis, provide highlyindeterminate and variable rates of diffusion and thus of total quantity of agent1015202530CA 02265906 l999-03- 11W0 98/1 1937 PCT/US97/ 16454introduced. In many applications, this indetenninacy is unacceptable, either because thetherapeutic agent is dangerous or costly in quantities exceeding the desired concentrationof the substance.Summary of the InventionIn accordance with one aspect of the invention, in one of its embodiments, there isprovided a method for causing the transport, as defined below, of a substance across anouter boundary of a porous medium. The method includes the steps of creating a pressuregradient along at least one path, each path running from a first zone of the porous mediumto a second zone of the porous medium proximate to the first zone, so that the pressure atthe second zone is below ambient pressure at the outer surface of the porous medium andcausing transport of the substance across the outer boundary of the porous mediumthrough at least one microfissure, where the term “microfissure” is also defined below.In alternate embodiments of the present invention, the may be drawn either into orout of the porous medium, the substance may be a liquid or a therapeutic agent, and theporous medium may be body tissue. The step of creating a pressure gradient may includepuncturing at least one microfissure in the outer boundary of the porous medium with atleast one micropenetrator. Additionally, the pressure gradient between zones of the porousmedium may be created by applying suction to a portion of the outer surface of the porousmedium, applying suction to a subset of the micropenetrators, and applying suction to asubset of the microfissures. In another embodiment of the present invention, at least onemicropenetrator is drawn into contact with the outer surface of the porous medium byapplying suction to a portion of the outer boundary of the porous medium substantiallysurrounding the contact between the micropenetrator and the outer boundary of the porousmedium.In accordance with a further aspect of the invention, there is provided an apparatusforcausing the transport of a substance across the outer boundary of a porous medium. Theapparatus has a platen with at least one orifice and at least one micropenetrator coupled tothe platen for cleaving microfissures in the outer boundary of the porous medium. Avacuum arrangement is provided for creating a pressure gradient along at least one path,CA 02265906 l999-03- 11W0 98/1 1937 PCT/US97/16454each path running from a first zone of the porous medium to a second zone of the porousmedium proximate to the first zone, so that the pressure at the second zone is belowambient pressure at the outer boundary of the porous medium. A reservoir is alsoprovided for supplying the substance to at least one micropenetrator so as to cause5 transport of the substance into the porous medium. In an alternative embodiment of theapparatus, there is provided a partial vacuum for drawing the outer surface of the porousmedium against at least one micropenetrator, while, in further alternate embodiments, atleast one sensor is provided, each sensor having an output, for monitoring the quantity ofsubstance transported into the porous medium and a controller for regulating the rate of1() substance supplied by the reservoir based on the sensor outputs. Additionally, at least onesensor may be provided for monitoring a biological response to the transport of thesubstance across the outer boundary of the porous medium and a controller for regulatingthe rate at which the substance is supplied based on the sensor output.In accordance with yet a further aspect of the invention, there is provided a method15 of manufacture for producing an apparatus for causing the transport of a substance acrossthe outer boundary of a porous medium. The method includes the steps of punching anarray of protrusions in the surface of a thin planar platen such as to create orifices in theplaten, coupling a first plenum to a first subset of the orifices in the platen, and coupling asecond plenum to a second set of the orifices in. the platen. In an alternate embodiment of2() the invention, the protrusions punched in the surface of the thin planar platen are conical.Another embodiment of the method-of—manufacture aspect of the inventionprovides an alternate method of manufacture for producing an apparatus for transporting asubstance across the boundary of a porous medium. The method includes the steps ofpunching an array of peninsular tongues in the surface of a thin planar platen, depressing25 the peninsular tongues below the surface of the platen such as to create orifices in theplaten, coupling a first plenum to a first subset of the orifices in the platen, and coupling asecond plenum to a second set of the orifices in the platen.The fluid transport system described herein advantageously provides the capabilityto introduce well—controlled and reproducible quantities of liquid agents through the30 epidermis without local trauma to the underlying dermis. An additional advantage of thepresent invention is to provide an inexpensive apparatus for introducing liquid agents1()15202530W0 98/11937CA 02265906 l999-03- llPCT/US97/16454through the epidermis. Other objects and advantages of the invention are in part apparentand in part pointed out hereinafter.Brief Description of the DrawingsThe invention will be more readily understood by reference to the following description,taken with the accompanying drawings, in which:FIG. 1 is a perspective view of a micropenetrator array according to anembodiment of the invention.FIG. 2 is a perspective view of a conical micropenetrator according to theembodiment of the invention of FIG. 1.FIG. 3 is a cross—sectional view showing a section of a row of the micropenetratorsof FIG. 1 penetrating the skin and further showing contours of equal concentration ofagent due solely to diffusion.FIG. 4 is a cross—sectional view showing a section of a row of the micropenetratorsof FIG. 1 penetrating the skin and further showing contours of equal pressure within theskin in the presence of suction.FIG. 5 is a cross—sectional view showing a section of a row of the micropenetratorsof FIG. 1 penetrating the skin and further showing contours of equal concentration ofagent due jointly to diffusion and suction.FIG. 6 is a cross—sectional view of a row of the micropenetrators of FIGS. 1 and 2according to an embodiment of the invention.FIG. 7 is a perspective view of a micropenetrator array according to an alternateembodiment of the invention.FIG. 8 is a cross—sectional view of a row of the micropenetrators of FIG. 7according to an alternate embodiment of the invention.FIG. 9 is an exploded view of an embodiment of the invention showing dual plenafor the joint application of suction and liquid agent.Detailed Description of Specific EmbodimentsMany useful therapeutic agents such as lidocaine, for topical application, andinsulin, may be introduced into the body by diffusion into the upper layers of the dermis.WO 98/119371015202530CA 02265906 l999-03- llPCT/US97/ 16454The dermis, consisting of live tissue, is highly permeable to fluids, such as the body’s ownlymphatic fluid. In order, however, to introduce external agents into the dermis fromoutside the body, it is necessary to traverse the stratus comeum of the epidermis whichhas extremely low permeability to fluids.The process whereby therapeutic agents or other substances, liquid or gaseous, aremoved into, out of, or through, tissue, whether by suction, diffusion, or by anycombination of density or pressure gradients, or otherwise, is referred to as “transport” inthis description and in the appended claims. Additionally, as used in this description andin the appended claims, the term “micropenetrator” refers to a sharp protuberance whichcan be used to puncture the dead skin of the epidermis without penetrating substantiallyinto the sensitive skin of the demris. By puncturing the epidermis, a micropenetrator maybe used effectively to introduce many therapeutic agents into the dermis. The size of theseparation in the epidermis required to enable penetration of a particular compounddepends upon the specific molecular structure of the compound. In some cases, the sizeneeded to pass a therapeutic agent may be microscopically small, on the order ofmicrometers. In this description and in the appended claims, the tenn “microfissure”refers to the separation in the epidermis through which therapeutic agent can be passedinto the dermis in accordance with this invention. Microfissures may occur naturally asmicroscopic cracks in the dermis, or may be induced in the skin, as described, through thepuncturing action of micropenetrators.In order for the therapeutic agent to be passed into the dermis in therapeuticallyuseful quantities, it may be necessary to employ a plurality of microfissures, eachconducting a fraction of the fluid agent to the dermis. A method and apparatus employingone or more micropenetrators to introduce fluid. through the epidermis into the dermis,and a means of manufacture of an apparatus for the same purpose, will now be describedwith reference to FIGS. 1-9, in which like reference numerals designate identical orcorresponding elements of the invention.Referring now to FIG. 1, a micropenetra.tor array is shown in perspective view anddesignated generally by numeral 10. Micropenetrator array 10 consists of a sheet 12composed of thin foil. In the preferred embodiment, sheet 12 is a hardened metal such asstainless steel, having a thickness of approximately 0.0005—().003 inches (0.5-3 mil, orCA 02265906 l999-03- 11W0 98/11937 PCT/US97/ 16454approximately 13-75 microns). Other materials may be employed, as may coatings andtreatments of sheet 12, all falling under the present invention as claimed. In thisdescription and in the appended claims, sheet 12 is referred to, also, as a “platen.” Theareal dimensions of platen 12 are typically on the order of l centimeter square, however5 larger or smaller dimensions are employed depending on the quantity of fluid to beintroduced into the body, and the rate at which fluid is advantageously introduced toachieve the requisite diffusion depth, as discussed in greater detail below. Platen 12 isreadily manufactured, as discussed below, and readily sterilized to prevent introduction ofinfectious or toxic materials through the epidermis.10 Micropenetrators are sharp edges produced in platen 12 by disrupting thecontinuity of platen 12 by an array of cuts, slots 14 (shown in FIG. 7) or protrusions. FIG.2 shows an embodiment of the present invention in which micropenetrator 60 is createdby punching through platen 12 leaving jagged edges 62 through which fluid may beintroduced through the stratus comeum. Other shapes of micropenetrator are within the15 scope of this invention, as discussed further below. The conical or volcano-like shape isshown as an example, though many other shapes of cuts or slots may be employed. In thepreferred embodiment, an array of, typically, 10 by 10 micropenetrators, is punched intoplaten 12. Referring, again, to FIG. 1, the spacing between micropenetrator 60 is on theorder of 0.10 inches (~2.5 mm), however the precise absolute and relative dimensions20 depend on the material and clinical parameters discussed below. In the preferredembodiment, the spacing of the array may be regular, as shown, or random, dependingupon the depth diffusion profile required. In the preferred embodiment, the sharp, jagged,and very strong edges 62 of micropenetrators 60, for separating the tissue of theepidermis, are produced by means of the manufacturing process discussed below. When25 platen 12 is pressed firmly against the skin of the subject, micropenetrators 60 penetratetoward the demiis by approximately the thickness of the typical epidermal layer, or, on theorder of 1 mil (~25 microns).The mechanism for introduction of fluid into the dennis is now described withreference to FIGS. 3-5 where the skin of the subject is shown in cross—section, with skin3() 20 constituting the interface between epidermis 22 and the ambient environment. Interface24 separates epidermis 22 from the dermis. Microfissures 26, as defined above, are10152025W0 98/11937CA 02265906 l999-03- llPCT/US97/ 16454separations of the epidermis caused by the cleaving action of micropenetrators. For theintroduction of certain fluid agents, it is unnecessary for the micropenetrator to protrudeoutside the plane of the platen since the epidermis is effectively separated by being drawnby a vacuum around the tight radius of curvature of the slot edges. The precise shape ofmicrofissures 26 may be cylindrical or irregular, and is not critical to this discussion. Themicropenetrators may be complete cannulae, however, this is unnecessary in many casessince the surface tension of the fluid and the capillary action at the epidemiis provide forthe guidance of fluid into microfissures 26.Whereas a liquid is conventionally injected into the body by imparting to the liquida pressure higher than the internal pressure within the body, a preferred embodiment ofthe present invention uses two other principles. One is diffusion - the propensity of aliquid to flow from a place of higher density to a place of lesser density. As is well knownin elementary physics, the flow J is proportional to the gradient of the density p of liquid,J=-a2Vp,where a is the diffusion constant and accounts for the percolation of the fluid through theskin tissue, and, particularly, for the molecular dimensions of the injected agent relative tothe porosity of the tissue. The sense of the proportionality reflects the fact that fluid flowsaway from regions of higher density toward regions of lower density. Since fluid 28introduced into the system via microfissure 30 is conserved,8p/6! = -v-J ,which expresses the fact that the flow out of a surface surrounding every infinitesimalvolume element equals the decrement in fluid contained within the element. Combinationof the last two equations results in a spatial distribution of fluid within the dermal tissue,considering diffusion alone, given by the diffusion equation,6p/at = a 2 Vzp .This behavior reflects the “wicking” action of the skin. Solution of the diffusion equationin three dimensions yields the precise distribution of fluid within the dermal tissue, inparticular, the contours of equal concentration of fluid 28 radiate from the bottom surface10152025CA 02265906 1999- 10- 1832 of the microfissure, with the concentration decreasing nearly exponentially into thedermis. Thus, if contour 34 represents a contour of half-saturation of the tissue, a contour36 of 1/4-saturation is half—again as deep into the dermis as contour 34 is from the bottomsurface 32 of the microfissure.However, for some agents which are beneficially introduced hypodermically,diffusion alone is inadequate to introduce effective quantities of agent into the dermis.The flow, J, of a fluid into a porous medium, such as the dermis, is also governed bypressure gradients, according to6.]/<9t+RJ=F-Vp,where R is an effective resistance (possibly a tensor, taking the structural profile of theskin into account) of the dermis to flow by the particular fluid being introduced; F is theforce, if any, applied to inject the fluid into the skin; and p is the field characterizing thepressure within the dermis. A pressure gradient, Vp, is created in the dermis by applicationof a vacuum or partial vacuum to a subset of the microfissures 26. Alternatively, thepressure gradient Vp, may be created by application of a vacuum or partial vacuumexternal to the epidermis 22, since the epidermis is permeable to the flow of air from thedermis outward. The effect of applying a vacuum or partial vacuum at a microfissure 40 isshown in FIG. 4. The bottom surface 42 is at the pressure p, of the partial vacuumapplied, while isobaric contours 43, 45, and 47 show successively increasing pressures,tending to the internal pressure p., of the dermis, which, due to the permeability of theepidermis, is substantially in equilibrium with the ambient pressure at the outside surfaceof the epidermis, that is, typically, at the ambient atmospheric pressure. Isobaric contours43, 45, and 47 denote zones of the porous medium between any two of which a pressuregradient is said to exist.To derive the distribution of liquid in the dermis as a function of time, whenvacuum is applied to some portions of the region of skin to which micropenetrators havebeen applied and liquid is applied to the dermis through microfissures, the diffusionequation is solved subject to the pressure constraints. The effect of applying a vacuum orpartial vacuum is shown in FIG. 5. A vacuum is applied at microfissure 40, or,alternatively, through the epidermis, creating 21 surface of low pressure at the bottomCA 02265906 l999-03- 11W0 98/ 1 1937 PCT/U S97/ 16454surface 42 of microfissure 40. The neighboring microfissure 44 allows liquid 28 to passthrough epidermis 22. By virtue of the pressure gradient created within the dermis,contours of equal concentration 48, 50, and 52 s.how more uniform penetration of theliquid into the dermis than in the absence of an applied vacuum, as well as a deeper5 penetration. The path of transport of liquid 28 into the porous medium is described bypath 54 which is orthogonal to contours 48, 50, and 52 and is directed from microfissure44 into which liquid 28 is introduced and toward microfissure 40 to which a partialvacuum is applied. The scenario of path 54 traversing contours 48, 50 and 52 from zonesof higher pressure toward zones of lower pressure may be repeated many times, withl() paths emanating from each microfissure 44 of higher pressure and directed toward eachmicrofissure 40 of lower pressure.The diffusion constant defines a scale which is a volume per depth—time product,in terms of which the size and spacing of the microholes and the differential pressureapplied between the liquid and the vacuum plena are optimized to provide penetration of15 the requisite depth for a therapeutic agent of given molecular structure.In order to provide a given area of interface between the liquid and the dermis, theratio of microfissure diameter to center-spacing must be traded off against total number ofmicrofissures. This requires solution of the above equations for the material parameters ofthe system which include the diffusion constant, a, of the particular agent in tissue, and20 the effective resistance R.FIG 6 shows the micropenetrator shape of FIGS. 1 and 2 in silhouette. An alternateshape of micropenetrator may now be appreciated with reference to FIG. 7. In thisalternate embodiment of the invention, micropenetrators are sharp edges produced inplaten 12 by disrupting the continuity of platen 12 by an array of cuts or slots 14. The25 chevron or half-moon shape is shown as an example, though many other shapes of cuts orslots may be employed. The slots, in this embodiment, are on the order of 0.050inches (~1.3 mm) in linear dimension.The micropenetrators, in this embodiment, for separating the tissue of the epidermis, areproduced by bending tongues 16 slightly out of the plane of platen 12 so that, when platen30 12 is pressed firmly against the skin of the subject, the micropenetrators penetrate towardthe dermis by approximately the thickness of the typical epidermal layer, or, on the order1015202530W0 98/1 1937CA 02265906 l999-03- llPCT/U S97/ 1645410of 1 mil (~25 microns). In FIG. 8, tongues 16 of FIG. 7 are shown, in cross—section, asdepressed out of the plane of platen 12.In order to create the configuration of alternating subregions of low pressure andinjected fluid, various embodiments may be employed. Referring now to FIG. 9, in thepreferred embodiment, platen 12 is secured to a region of the skin of the subject by meansof an adhesive material 70. Dual manifold 72 provides coupling between a subset of slots14 and plenum 74, and through-passages 82 to allow air to be drawn between plenum 76and a complementary subset of slots 14 without communication with plenum 74. Avacuum is drawn through hose 80 on plenum 76, and, thereby, via the interconnected slots14, on the skin of the subject. Means, such as mechanical pumps or chemical reactions,are well known in the art for production of a vacuum or partial vacuum. While a vacuumis being drawn via plenum 76, fluid may be introduced into the dermis through hose 78,or, more generally, from any kind of reservoir, through plenum 74, and interconnectedslots 14. The fluid is ordinarily at ambient pressure, however, in cases where more rapidinfusion into the skin is indicated, additional pressure may be applied to the fluid via hose78 and plenum 74. The amount and rate of transport may additionally be monitored bysensors of volume or concentration of fluid within the skin, or, alternatively by sensors offlow rate or volume of fluid within the delivery device, or, in a further alternateembodiment, by means of monitoring some biological response such as blood glucoselevel, for example. In applications where this is desirable, the rate of introduction of thefluid into the dermis may be regulated by a controller, in a closed loop, in response toquantities measured by any of the aforementioned sensors.In yet another alternate embodiment, a single plenum 76 is employed, sealingplaten 12 to all passage of air other than through slots 14. In this embodiment, platen 12 ispositioned adjacent to a region of the skin of a subject and secured by an adhesivematerial 70, by vacuum suction, or by directly applied force. A vacuum is drawn throughslots 14 of platen 12 by withdrawing air through vacuum hose 80, using conventionalpumping means. Not only is the skin surface drawn up against platen 12 by the vacuum,but, additionally, a pressure gradient is created within the dermis of the subject since air isalso drawn through the epidermis due to its finite permeability to air. Additionally,micropenetrators, which are edges 15 of slots 14, are introduced into the epidermis by10CA 02265906 l999-03- 11W0 98/ 11937 PCT/U S97/ 1645411virtue of the skin having been drawn against platen 12. By operation of an external valve(not shown), fluid is introduced into hose 80, backfilling plenum 76, and is drawn throughslots 14 and micropenetrators 16 into the dermis.The methods described herein may be applied in other applications besides theclinical applications in terms of which the invention has been described. Generally, theinvention may be applied to achieve a particular distribution of a liquid within a porousmedium, where the medium is accessible from only one side. The described embodimentsof the invention are intended to be merely exemplary and numerous variations andmodifications will be apparent to those skilled in the art. All such variations andmodifications are intended to be within the scope of the present invention as defined inthe appended claims.

Claims (16)

The Embodiments Of The Invention In Which An Exclusive Property Or Privilege Is Claimed Are Defined As Follows:
1. An apparatus for causing the transport of a substance across an outer boundary of a permeable medium, the apparatus comprising:
a. a micropenetrator for penetrating the outer surface of a first zone of the permeable medium to a depth no greater than 1000 micrometers, thereby creating a microfissure;
b. a vacuum arrangement that applies a partial vacuum to a second zone of the permeable medium, the second zone proximate to the first zone, thereby creating a pressure gradient along a path running from the microfissure to the second zone of the permeable medium, so that the pressure at the second zone is below ambient pressure external to the outer boundary of the permeable medium; and c. a reservoir for supplying a substance to the micropenetrator so as to cause transport of the substance into the permeable medium.
2. An apparatus according to claim 1, further comprising:
a. at least one sensor having an output for monitoring the quantity of the substance transported across the outer boundary of the permeable medium; and b. a controller for regulating the rate of supply of the substance by the reservoir based on the output of each sensor.
3. An apparatus according to claim 1, further comprising:
a. at least one sensor having an output for monitoring a biological response to transport of the substance across the outer boundary of the permeable medium;
and b. a controller for regulating the rate of supply of the substance supplied by the reservoir based on the output of each sensor.
4. An apparatus according to claim 1 further comprising a partial vacuum for drawing the outer surface of the permeable medium against at least one micropenetrator.
5. An apparatus for transporting a substance across the outer boundary of a permeable medium, the apparatus comprising:

a. a platen having a first and a second orifice, the first orifice characterized by a first pressure and the second orifice characterized by a second pressure, the difference between the first pressure and the second pressure causing a pressure gradient parallel to the outer boundary of the permeable medium;

b. at least one micropenetrator coupled to the platen for cleaving at least one microfissure in the outer boundary of the permeable medium; and c. an arrangement for guiding a substance into the permeable medium via the at least one microfissure based at least in part on the pressure gradient.
6. A method of manufacture for producing an apparatus for transporting a substance across the outer boundary of a permeable medium, the method comprising:

a. punching an array of protrusions having central orifices in the surface of a thin planar platen;

b. coupling a plenum to a first subset of the orifices in the platen; and c. coupling suction means to a second subset of the orifices in the platen.
7. A method of manufacture according to claim 6, wherein the step of punching an array of protrusions includes punching conical protrusions.
8. A method of manufacture for producing an apparatus for transporting a substance across the outer boundary of a permeable medium, the method comprising:

a. punching an array of peninsular tongues in the surface of a thin planar platen;

b. depressing the peninsular tongues below the surface of the platen such as to create orifices in the platen;

c. coupling a first plenum to a first subset of the orifices in the platen , and;

d. coupling a second plenum to a second set of the orifices in the platen.
9. A use of the apparatus defined by claim 1, for transporting a substance across an outer boundary of a permeable medium having at least one microfissure.
10. The use according to claim 9, wherein the substance is drawn into the permeable medium.
11. The use according to claim 9, wherein the substance is drawn out of the permeable medium.
12. The use according to claim 9, wherein the substance is a liquid.
13. The use according to claim 9, wherein the substance is a therapeutic agent.
14. The use according to claim 9, wherein the permeable medium is body tissue.
15. The use according to claim 9, wherein the pressure at the second zone in below ambient pressure exterior to the outer boundary of the permeable medium.
16. The use of the apparatus defined by claim 1 for transporting a substance across the outer boundary of a permeable medium.
CA002265906A 1996-09-17 1997-09-15 System for delivery of drugs by transport Expired - Lifetime CA2265906C (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US2626696P 1996-09-17 1996-09-17
US60/026,266 1996-09-17
US3903697P 1997-02-24 1997-02-24
US60/039,036 1997-02-24
PCT/US1997/016454 WO1998011937A1 (en) 1996-09-17 1997-09-15 System for delivery of drugs by transport

Publications (2)

Publication Number Publication Date
CA2265906A1 CA2265906A1 (en) 1998-03-26
CA2265906C true CA2265906C (en) 2003-11-11

Family

ID=26700996

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002265906A Expired - Lifetime CA2265906C (en) 1996-09-17 1997-09-15 System for delivery of drugs by transport

Country Status (7)

Country Link
US (1) US5983136A (en)
EP (1) EP0934093B1 (en)
JP (2) JP4054381B2 (en)
AT (1) ATE231015T1 (en)
CA (1) CA2265906C (en)
DE (1) DE69718495T2 (en)
WO (1) WO1998011937A1 (en)

Families Citing this family (135)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996037256A1 (en) * 1995-05-22 1996-11-28 Silicon Microdevices, Inc. Micromechanical patch for enhancing the delivery of compounds through the skin
US7214847B1 (en) 1997-09-22 2007-05-08 Argentum Medical, L.L.C. Multilayer conductive appliance having wound healing and analgesic properties
US6861570B1 (en) * 1997-09-22 2005-03-01 A. Bart Flick Multilayer conductive appliance having wound healing and analgesic properties
US8455710B2 (en) * 1997-09-22 2013-06-04 Argentum Medical, Llc Conductive wound dressings and methods of use
US8801681B2 (en) * 1995-09-05 2014-08-12 Argentum Medical, Llc Medical device
US5814094A (en) 1996-03-28 1998-09-29 Becker; Robert O. Iontopheretic system for stimulation of tissue healing and regeneration
US6230051B1 (en) * 1996-06-18 2001-05-08 Alza Corporation Device for enhancing transdermal agent delivery or sampling
EP2428249B1 (en) * 1998-07-13 2015-10-07 Inovio Pharmaceuticals, Inc. Skin and muscle-targeted gene therapy by pulsed electrical field
US7922709B2 (en) 1998-07-13 2011-04-12 Genetronics, Inc. Enhanced delivery of naked DNA to skin by non-invasive in vivo electroporation
US6678556B1 (en) * 1998-07-13 2004-01-13 Genetronics, Inc. Electrical field therapy with reduced histopathological change in muscle
US6256533B1 (en) 1999-06-09 2001-07-03 The Procter & Gamble Company Apparatus and method for using an intracutaneous microneedle array
AU6076200A (en) 1999-07-08 2001-01-30 Johnson & Johnson Consumer Companies, Inc. Exothermic bandage
US6890553B1 (en) 1999-07-08 2005-05-10 Johnson & Johnson Consumer Companies, Inc. Exothermic topical delivery device
US20030078499A1 (en) * 1999-08-12 2003-04-24 Eppstein Jonathan A. Microporation of tissue for delivery of bioactive agents
US7113821B1 (en) 1999-08-25 2006-09-26 Johnson & Johnson Consumer Companies, Inc. Tissue electroperforation for enhanced drug delivery
US7133717B2 (en) 1999-08-25 2006-11-07 Johnson & Johnson Consumer Companies, Inc. Tissue electroperforation for enhanced drug delivery and diagnostic sampling
US6502574B2 (en) 1999-09-17 2003-01-07 Pi Medical, Inc. Lateral stiffening snoring treatment
US6431174B1 (en) 2000-08-10 2002-08-13 Pi Medical, Inc. Method and apparatus to treat conditions of the naso-pharyngeal area
US6231561B1 (en) * 1999-09-20 2001-05-15 Appriva Medical, Inc. Method and apparatus for closing a body lumen
US8465468B1 (en) 2000-06-29 2013-06-18 Becton, Dickinson And Company Intradermal delivery of substances
CN1390148A (en) * 1999-11-15 2003-01-08 维尔克鲁工业公司 Skin attachment member
EP1239916B1 (en) 1999-12-10 2005-11-23 ALZA Corporation Device and method for enhancing microprotrusion skin piercing
US6497676B1 (en) 2000-02-10 2002-12-24 Baxter International Method and apparatus for monitoring and controlling peritoneal dialysis therapy
US7404815B2 (en) 2000-05-01 2008-07-29 Lifescan, Inc. Tissue ablation by shear force for sampling biological fluids and delivering active agents
US6659982B2 (en) * 2000-05-08 2003-12-09 Sterling Medivations, Inc. Micro infusion drug delivery device
US6595947B1 (en) 2000-05-22 2003-07-22 Becton, Dickinson And Company Topical delivery of vaccines
US6440096B1 (en) * 2000-07-14 2002-08-27 Becton, Dickinson And Co. Microdevice and method of manufacturing a microdevice
NZ524646A (en) 2000-09-08 2004-10-29 Alza Corp Methods for inhibiting decrease in transdermal drug flux by inhibition of pathway closure
CN1250171C (en) 2000-10-13 2006-04-12 阿尔扎公司 Apparatus and method for piercing skin with microtrusions
US7419481B2 (en) 2000-10-13 2008-09-02 Alza Corporation Apparatus and method for piercing skin with microprotrusions
JP4198985B2 (en) 2000-10-13 2008-12-17 アルザ・コーポレーシヨン Microblade array impact applicator.
MXPA03003303A (en) * 2000-10-13 2004-12-13 Johnson & Johnson Microprotrusion member retainer for impact applicator.
US7131987B2 (en) 2000-10-16 2006-11-07 Corium International, Inc. Microstructures and method for treating and conditioning skin which cause less irritation during exfoliation
US7108681B2 (en) 2000-10-16 2006-09-19 Corium International, Inc. Microstructures for delivering a composition cutaneously to skin
US7828827B2 (en) 2002-05-24 2010-11-09 Corium International, Inc. Method of exfoliation of skin using closely-packed microstructures
ATE428466T1 (en) 2000-10-26 2009-05-15 Alza Corp TRANSDERMAL DRUG DELIVERY SYSTEM WITH COATED MICROPROOFS
MXPA03006852A (en) 2001-01-31 2004-05-31 Velcro Ind Direct hook engagement.
US6663820B2 (en) 2001-03-14 2003-12-16 The Procter & Gamble Company Method of manufacturing microneedle structures using soft lithography and photolithography
WO2002074173A1 (en) 2001-03-16 2002-09-26 Alza Corporation Method and apparatus for coating skin piercing microprojections
EP1752189A3 (en) 2001-04-20 2007-02-21 Alza Corporation Microprojection array having a beneficial agent containing coating
MXPA03009603A (en) * 2001-04-20 2004-12-06 Johnson & Johnson Microprojection array having a beneficial agent containing coating.
US20020193729A1 (en) * 2001-04-20 2002-12-19 Cormier Michel J.N. Microprojection array immunization patch and method
US6790179B2 (en) 2001-08-01 2004-09-14 Johnson & Johnson Consumer Companies, Inc. Method of examining and diagnosing skin health
US6840910B2 (en) 2001-08-01 2005-01-11 Johnson & Johnson Consumer Companies, Inc. Method of distributing skin care products
US6855117B2 (en) 2001-08-01 2005-02-15 Johnson & Johnson Consumer Companies, Inc. Method of treating the skin of a subject
US7429258B2 (en) * 2001-10-26 2008-09-30 Massachusetts Institute Of Technology Microneedle transport device
US20040120964A1 (en) * 2001-10-29 2004-06-24 Mikszta John A. Needleless vaccination using chimeric yellow fever vaccine-vectored vaccines against heterologous flaviviruses
JP2005511248A (en) * 2001-10-29 2005-04-28 ベクトン・ディキンソン・アンド・カンパニー Methods and devices for delivering substances
US20030125662A1 (en) 2002-01-03 2003-07-03 Tuan Bui Method and apparatus for providing medical treatment therapy based on calculated demand
US7146981B2 (en) * 2002-02-04 2006-12-12 Restore Medical, Inc. Pharyngeal wall treatment
US7017582B2 (en) * 2002-02-04 2006-03-28 Restore Medical Inc. Stiffening pharyngeal wall treatment
US9918665B2 (en) 2002-03-11 2018-03-20 Nitto Denko Corporation Transdermal porator and patch system and method for using same
AU2003265226A1 (en) 2002-03-11 2003-12-19 Altea Therapeutics Corporation Transdermal drug delivery device, method and use
US8116860B2 (en) 2002-03-11 2012-02-14 Altea Therapeutics Corporation Transdermal porator and patch system and method for using same
US6945952B2 (en) 2002-06-25 2005-09-20 Theraject, Inc. Solid solution perforator for drug delivery and other applications
KR20120087197A (en) 2002-07-19 2012-08-06 쓰리엠 이노베이티브 프로퍼티즈 컴파니 Microneedle device, method of using microneedle device and method of delivering microneedle device
US7238164B2 (en) 2002-07-19 2007-07-03 Baxter International Inc. Systems, methods and apparatuses for pumping cassette-based therapies
US20040194266A1 (en) * 2002-08-19 2004-10-07 Carter Linda A. Burn, sunburn, and cellulite treatment system
CA2497154C (en) * 2002-08-29 2012-01-03 Becton, Dickinson And Company Substance delivery via a rotating microabrading surface
US8062573B2 (en) * 2002-09-16 2011-11-22 Theraject, Inc. Solid micro-perforators and methods of use
US20040236269A1 (en) 2002-09-25 2004-11-25 Marchitto Kevin S. Microsurgical tissue treatment system
US7390330B2 (en) 2002-09-27 2008-06-24 Surgitech, Llc Reciprocating surgical file
US7666186B2 (en) * 2002-09-27 2010-02-23 Surgitech, Llc Surgical system with a blade
US20060264926A1 (en) * 2002-11-08 2006-11-23 Kochamba Gary S Cutaneous stabilization by vacuum for delivery of micro-needle array
US6896666B2 (en) * 2002-11-08 2005-05-24 Kochamba Family Trust Cutaneous injection delivery under suction
US7381222B2 (en) * 2002-12-30 2008-06-03 Quiescence Medical, Inc. Stent for maintaining patency of a body region
US7992566B2 (en) 2002-12-30 2011-08-09 Quiescence Medical, Inc. Apparatus and methods for treating sleep apnea
US7647931B2 (en) 2002-12-30 2010-01-19 Quiescence Medical, Inc. Stent for maintaining patency of a body region
US7578954B2 (en) 2003-02-24 2009-08-25 Corium International, Inc. Method for manufacturing microstructures having multiple microelements with through-holes
US20050123507A1 (en) * 2003-06-30 2005-06-09 Mahmoud Ameri Formulations for coated microprojections having controlled solubility
CA2530531A1 (en) 2003-06-30 2005-01-20 Alza Corporation Formulations for coated microprojections containing non-volatile counterions
AR044985A1 (en) * 2003-07-02 2005-10-12 Alza Corp IMMUNIZATION METHOD AND PATCH BY MICROPROJECTION PROVISION
US8961477B2 (en) 2003-08-25 2015-02-24 3M Innovative Properties Company Delivery of immune response modifier compounds
CA2536443A1 (en) * 2003-08-26 2005-03-03 Alza Corporation Device and method for intradermal cell implantation
US8016811B2 (en) * 2003-10-24 2011-09-13 Altea Therapeutics Corporation Method for transdermal delivery of permeant substances
JP2007510445A (en) 2003-10-24 2007-04-26 アルザ・コーポレーシヨン Pretreatment methods and systems for promoting transdermal drug delivery
BRPI0415986A (en) 2003-10-28 2007-01-23 Alza Corp method and apparatus for reducing the incidence of tobacco use
JP4682144B2 (en) 2003-10-31 2011-05-11 アルザ・コーポレーシヨン Self-actuating applicator for microprojection arrays
EP1706171A1 (en) * 2003-12-29 2006-10-04 3M Innovative Properties Company Medical devices and kits including same
JP2007523771A (en) * 2004-02-23 2007-08-23 スリーエム イノベイティブ プロパティズ カンパニー Microneedle array molding method
WO2005094526A2 (en) 2004-03-24 2005-10-13 Corium International, Inc. Transdermal delivery device
AU2005244734A1 (en) 2004-05-13 2005-12-01 Alza Corporation Apparatus and method for transdermal delivery of parathyroid hormone agents
WO2005123173A1 (en) * 2004-06-10 2005-12-29 3M Innovative Properties Company Patch application device and kit
US7316665B2 (en) * 2004-08-25 2008-01-08 Becton, Dickinson And Company Method and device for the delivery of a substance including a covering
KR20070099540A (en) * 2004-09-08 2007-10-09 알자 코포레이션 Microprojection array with improved skin adhesion and compliance
JP5015787B2 (en) 2004-11-18 2012-08-29 スリーエム イノベイティブ プロパティズ カンパニー Contact coating method of microneedle array
BRPI0517749A (en) 2004-11-18 2008-10-21 3M Innovative Properties Co application device for applying a micro-needle device to a skin surface, and method for using an application device
KR101224257B1 (en) * 2004-11-18 2013-01-18 쓰리엠 이노베이티브 프로퍼티즈 컴파니 Masking method for coating a microneedle array
US9174035B2 (en) 2004-11-18 2015-11-03 3M Innovative Properties Company Microneedle array applicator and retainer
US8057842B2 (en) 2004-11-18 2011-11-15 3M Innovative Properties Company Method of contact coating a microneedle array
US20080307849A1 (en) * 2004-11-26 2008-12-18 Agency For Science, Technology And Research Method And Apparatus For Forming Microstructures
AU2005314151B2 (en) 2004-12-07 2011-09-08 3M Innovative Properties Company Method of molding a microneedle
WO2006108185A1 (en) 2005-04-07 2006-10-12 3M Innovative Properties Company System and method for tool feedback sensing
US20070270738A1 (en) * 2005-04-25 2007-11-22 Wu Jeffrey M Method of treating ACNE with stratum corneum piercing patch
US20060253078A1 (en) * 2005-04-25 2006-11-09 Wu Jeffrey M Method of treating skin disorders with stratum corneum piercing device
US20080009802A1 (en) * 2005-04-25 2008-01-10 Danilo Lambino Method of treating acne with stratum corneum piercing device
EP1904158B1 (en) 2005-06-24 2013-07-24 3M Innovative Properties Company Collapsible patch with microneedle array
ATE477833T1 (en) * 2005-06-27 2010-09-15 3M Innovative Properties Co MICRONEEDLE CARTRIDGE ASSEMBLY
JP5144510B2 (en) 2005-06-27 2013-02-13 スリーエム イノベイティブ プロパティズ カンパニー Microneedle array application device
CN101687094B (en) * 2005-09-06 2012-09-26 谢拉杰克特股份有限公司 Solid solution perforator containing drug particle and/or drug-adsorbed particles
WO2007061964A1 (en) * 2005-11-18 2007-05-31 3M Innovative Properties Company Methods for coating microneedles
US20080262416A1 (en) * 2005-11-18 2008-10-23 Duan Daniel C Microneedle Arrays and Methods of Preparing Same
US20070142885A1 (en) * 2005-11-29 2007-06-21 Reliant Technologies, Inc. Method and Apparatus for Micro-Needle Array Electrode Treatment of Tissue
WO2007075614A1 (en) * 2005-12-21 2007-07-05 3M Innovative Properties Company Microneedle devices
WO2007124411A1 (en) 2006-04-20 2007-11-01 3M Innovative Properties Company Device for applying a microneedle array
WO2008006090A2 (en) 2006-07-06 2008-01-10 Quiescence Medical, Inc. Apparatus and methods for treating sleep apnea
WO2008091602A2 (en) 2007-01-22 2008-07-31 Corium International, Inc. Applicators for microneedle arrays
US8558964B2 (en) 2007-02-15 2013-10-15 Baxter International Inc. Dialysis system having display with electromagnetic compliance (“EMC”) seal
US7998115B2 (en) 2007-02-15 2011-08-16 Baxter International Inc. Dialysis system having optical flowrate detection
US8361023B2 (en) 2007-02-15 2013-01-29 Baxter International Inc. Dialysis system with efficient battery back-up
US7731689B2 (en) 2007-02-15 2010-06-08 Baxter International Inc. Dialysis system having inductive heating
US8870812B2 (en) 2007-02-15 2014-10-28 Baxter International Inc. Dialysis system having video display with ambient light adjustment
WO2008130587A2 (en) 2007-04-16 2008-10-30 Corium International, Inc. Solvent-cast microneedle arrays containing active
US8911749B2 (en) 2007-04-16 2014-12-16 Corium International, Inc. Vaccine delivery via microneedle arrays
EP2244746B2 (en) † 2008-02-27 2019-01-02 Aplion Medical Corporation Wound dressing with uniform distribution
CN102105108B (en) * 2008-05-21 2013-12-04 谢拉杰克特股份有限公司 Method of manufacturing solid solution peforator patches and uses thereof
AU2011248108B2 (en) 2010-05-04 2016-05-26 Corium Pharma Solutions, Inc. Method and device for transdermal delivery of parathyroid hormone using a microprojection array
WO2012078649A1 (en) 2010-12-06 2012-06-14 Follica, Inc. Methods for treating baldness and promoting hair growth
US9265649B2 (en) 2010-12-13 2016-02-23 Quiescence Medical, Inc. Apparatus and methods for treating sleep apnea
CN105073178B (en) 2012-12-21 2019-07-30 考里安国际公司 Microarray and its application method for therapeutic agent delivering
WO2014126101A1 (en) 2013-02-13 2014-08-21 久光製薬株式会社 Microneedle array
WO2014164314A1 (en) 2013-03-12 2014-10-09 Corium International, Inc. Microprojection applicators
EP2968118B1 (en) 2013-03-15 2022-02-09 Corium, Inc. Microarray for delivery of therapeutic agent and methods of use
WO2014150285A2 (en) 2013-03-15 2014-09-25 Corium International, Inc. Multiple impact microprojection applicators and methods of use
JP2016512754A (en) 2013-03-15 2016-05-09 コリウム インターナショナル， インコーポレイテッド Microarray, method of use and manufacturing for delivery of therapeutic agents
EP2968116A1 (en) 2013-03-15 2016-01-20 Corium International, Inc. Microarray with polymer-free microstructures, methods of making, and methods of use
US20150038897A1 (en) 2013-07-30 2015-02-05 Zosano Pharma, Inc. Low-Profile Microneedle Patch Applicator
EP2905047A1 (en) * 2014-02-10 2015-08-12 LTS LOHMANN Therapie-Systeme AG Micro-needle system and method for producing the same
US10624843B2 (en) 2014-09-04 2020-04-21 Corium, Inc. Microstructure array, methods of making, and methods of use
WO2017004067A1 (en) 2015-06-29 2017-01-05 Corium International, Inc. Microarray for delivery of therapeutic agent, methods of use, and methods of making
EP3380061A4 (en) 2015-11-24 2019-07-24 Insulet Corporation Wearable automated medication delivery system
US11179516B2 (en) 2017-06-22 2021-11-23 Baxter International Inc. Systems and methods for incorporating patient pressure into medical fluid delivery
KR102291392B1 (en) * 2018-03-30 2021-08-20 랩앤피플주식회사 Multi type micro-needle
US20230277759A1 (en) 2022-03-03 2023-09-07 Deka Products Limited Partnership Systems, Methods, and Apparatuses for Medical Agent Administration
US20240024566A1 (en) 2022-07-21 2024-01-25 Deka Products Limited Partnership Delivery Device Systems, Methods, and Apparatuses

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3617613A (en) * 1968-10-17 1971-11-02 Spaulding Fibre Co Punchable printed circuit board base
US3675766A (en) * 1970-02-04 1972-07-11 Sol Roy Rosenthal Multiple puncture injector device
US3964482A (en) * 1971-05-17 1976-06-22 Alza Corporation Drug delivery device
BE795384A (en) * 1972-02-14 1973-08-13 Ici Ltd DRESSINGS
BR7908937A (en) * 1978-12-06 1981-06-30 Svedman Paul DEVICE FOR TREATING FABRICS, FOR EXAMPLE, SKIN
US4403609A (en) * 1981-02-24 1983-09-13 Cohen Edgar C Vacuum-compression injector
US4421508A (en) * 1981-02-24 1983-12-20 Cohen Edgar C Vacuum-compression injector
US4340048A (en) * 1981-03-28 1982-07-20 Alza Corporation Self-driven hypodermic injector
US4447225A (en) * 1982-03-22 1984-05-08 Taff Barry E Multidose jet injector
EP0209644A1 (en) * 1985-05-02 1987-01-28 Ivac Corporation Electrochemically driven drug dispenser
US4711247A (en) * 1986-04-18 1987-12-08 Henry Fishman Allergy testing method and apparatus
US5080648A (en) * 1987-06-08 1992-01-14 Antonio Nicholas F D Hypodermic fluid dispenser
DE3735137A1 (en) * 1987-10-16 1989-05-03 Siemens Ag ARRANGEMENT FOR DISPENSING MEDICINES IN AN IMPLANTABLE MEDICAL DEVICE
EP0347190A1 (en) * 1988-06-14 1989-12-20 Vci Corporation Needleless vacuum-compression injector
GB2221394B (en) * 1988-08-05 1992-03-04 Eilert Eilertsen An injection device
JPH02144077A (en) * 1988-11-25 1990-06-01 Olympus Optical Co Ltd Drug administration apparatus
EP0429842B1 (en) * 1989-10-27 1996-08-28 Korea Research Institute Of Chemical Technology Device for the transdermal administration of protein or peptide drug
US5279544A (en) * 1990-12-13 1994-01-18 Sil Medics Ltd. Transdermal or interdermal drug delivery devices
SE9101022D0 (en) * 1991-01-09 1991-04-08 Paal Svedman MEDICAL SUSPENSION DEVICE
US5312456A (en) * 1991-01-31 1994-05-17 Carnegie Mellon University Micromechanical barb and method for making the same
US5153986A (en) * 1991-07-17 1992-10-13 International Business Machines Method for fabricating metal core layers for a multi-layer circuit board
US5484399A (en) * 1992-02-27 1996-01-16 Sloan-Kettering Institute For Cancer Research Process and device to reduce interstitial fluid pressure in tissue
US5309909A (en) * 1992-05-22 1994-05-10 Physio-Control Corporation Combined skin preparation and monitoring electrode
US5702359A (en) * 1995-06-06 1997-12-30 Genetronics, Inc. Needle electrodes for mediated delivery of drugs and genes
IE68890B1 (en) * 1993-04-08 1996-07-24 Elan Med Tech Intradermal delivery device
DE59505328D1 (en) * 1994-12-09 1999-04-15 Novartis Ag TRANSDERMAL SYSTEM
EP0858285A4 (en) * 1995-08-29 2000-05-17 Spectrx Inc Microporation of human skin for drug delivery and monitoring applications
DE69722414T2 (en) * 1996-07-03 2004-05-19 Altea Therapeutics Corp. MULTIPLE MECHANICAL MICROPERFORATION OF SKIN OR MUCOSA

Also Published As

Publication number Publication date
DE69718495D1 (en) 2003-02-20
US5983136A (en) 1999-11-09
JP2007325955A (en) 2007-12-20
JP2002510982A (en) 2002-04-09
CA2265906A1 (en) 1998-03-26
DE69718495T2 (en) 2003-11-20
WO1998011937A1 (en) 1998-03-26
JP4054381B2 (en) 2008-02-27
ATE231015T1 (en) 2003-02-15
EP0934093B1 (en) 2003-01-15
EP0934093A1 (en) 1999-08-11

Similar Documents

Publication Publication Date Title
CA2265906C (en) System for delivery of drugs by transport
US6183434B1 (en) Multiple mechanical microporation of skin or mucosa
US20220040465A1 (en) Microneedle array assembly, drug delivery device and method for administering liquid across a broad area at low pressure
US6607513B1 (en) Device for withdrawing or administering a substance and method of manufacturing a device
US10524730B2 (en) Medical devices with microneedle arrays and methods for operating such medical devices
DE60124917T2 (en) MICRO-DEVICE AND METHOD OF MANUFACTURE
AU2002330234B2 (en) Microdevice and method of delivering or withdrawing a substance through the skin of an animal
US10525244B2 (en) Microneedle arrays and methods for fabricating microneedle arrays
DE69838389T2 (en) REGENERATION OF BIOSENSORS
US6969351B2 (en) Device and method for removing liquid from endogenic tissue and determining the concentrations of substance in said liquid
DE102006028782A1 (en) Micro needles storing and transporting device for use in e.g. biochemical area, has active substance-permeable carrier running through reservoir and sub-dividing it into reservoir area with micro needles and another area without needles
DE1162971B (en) Tuberculin test strips

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20170915